ZYUS Life Sciences (ZYUS) Stock Price & Analysis

8 Followers

ZYUS Stock Chart & Stats

CA$0.36CA$0.04(12.50%)

At close: Nov 10 4:00 PM EST

Day’s Range: CAD 0.36 - CAD 0.36
52-Week Range: CAD 0.30 - CAD 0.75
Previous Close: CAD 0.32
Volume: N/A
Average Volume (3M): 6,753
Market Cap: CAD 28.99M
Enterprise Value: CAD 67.01M
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): CAD 0
Price to Earnings (P/E): ―
Beta: 0.27
Next Earnings: Nov 26, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

ZYUS Life Sciences News

ZYUS Raises C$50,000 in Second Private-Placement Tranche

ZYUS Life Sciences ( ($TSE:ZYUS) ) just unveiled an update. ZYUS issued 111,110 units at C$0.45 each in its second tranche, raising C$50,000 and bringing total proceeds from the first

4d agoZYUS

ZYUS Life Sciences Closes Insider-Funded First Tranche of Private Placement

ZYUS Life Sciences ( ($TSE:ZYUS) ) just unveiled an update. ZYUS Life Sciences has closed the first tranche of its non-brokered private placement unit offering, issuing 444,444 units at C$0.45

2w agoZYUS

ZYUS Posts Positive Phase 2a Data for Non-Opioid Cancer Pain Drug Trichomylin

ZYUS Life Sciences ( ($TSE:ZYUS) ) has issued an update. ZYUS Life Sciences reported positive topline results from its Phase 2a UTOPIA-1 trial of Trichomylin softgel capsules in patients with

1M agoZYUS

ZYUS to Unveil Phase 2a Cancer Pain Trial Results as Governance Team Evolves

ZYUS Life Sciences ( ($TSE:ZYUS) ) has provided an update. ZYUS Life Sciences said it plans to release topline data from its Phase 2a UTOPIA-1 trial of Trichomylin softgel capsules,

1M agoZYUS

ZYUS Life Sciences Secures CAD$1.9 Million Loan Financing With Insider Participation

The latest announcement is out from ZYUS Life Sciences ( ($TSE:ZYUS) ). ZYUS Life Sciences Corporation has completed a secured loan financing through its wholly owned subsidiary ZYUS Life Sciences

2M agoZYUS

ZYUS Life Sciences closes ninth tranche of secured loan financing to bolster working capital

ZYUS Life Sciences ( ($TSE:ZYUS) ) has issued an update. ZYUS Life Sciences Corporation has closed the ninth tranche of its secured loan financing through its subsidiary ZYUS Life Sciences

2M agoZYUS

ZYUS Reaches Key Milestone in Phase 2a Trial of Non-Opioid Cancer Pain Drug

ZYUS Life Sciences ( ($TSE:ZYUS) ) just unveiled an update. ZYUS Life Sciences said the final patient in its Phase 2a UTOPIA-1 trial of Trichomylin softgel capsules for moderate to

6M agoZYUS

ZYUS Reaches Key Milestone in Phase 2a Trial of Non-Opioid Cancer Pain Drug

ZYUS Life Sciences ( ($TSE:ZYUS) ) has shared an announcement. ZYUS Life Sciences has completed the final patient visit in its Phase 2a UTOPIA-1 trial, a single-arm proof-of-concept study evaluating

6M agoZYUS

ZYUS Life Sciences Closes Unit Offering and Draws on Credit Line

An announcement from ZYUS Life Sciences ( ($TSE:ZYUS) ) is now available. ZYUS Life Sciences has confirmed that its previously announced non‑brokered private placement has closed with a single tranche,

7M agoZYUS

ZYUS Life Sciences Closes First Tranche of Downsized Private Placement

An announcement from ZYUS Life Sciences ( ($TSE:ZYUS) ) is now available. ZYUS Life Sciences has closed the first tranche of its downsized non-brokered private placement, issuing 451,269 units at

7M agoZYUS

Stifel starts Zyus Life Sciences with a Speculative Buy rating, C$4 price target

As previously reported last night, Stifel initiated coverage of Zyus Life Sciences with a Speculative Buy rating and C$4 price target. Founder, President and CEO Brent Zettl has been pursuing

3y agoZYUS

Zyus Life Sciences initiated with a Speculative Buy at Stifel

Stifel analyst Andrew Partheniou initiated coverage of Zyus Life Sciences with a Speculative Buy rating and C$4 price target. Published first on TheFly – the ultimate source for real-time, market-moving

3y agoZYUS

ZYUS FAQ

What was ZYUS Life Sciences’s price range in the past 12 months?

ZYUS Life Sciences lowest stock price was C$0.30 and its highest was C$0.75 in the past 12 months.

What is ZYUS Life Sciences’s market cap?

ZYUS Life Sciences’s market cap is C$28.99M.

When is ZYUS Life Sciences’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were ZYUS Life Sciences’s earnings last quarter?

ZYUS Life Sciences released its earnings results on Jul 20, 2026. The company reported -C$0.038 earnings per share for the quarter.

Is ZYUS Life Sciences overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does ZYUS Life Sciences pay dividends?

ZYUS Life Sciences does not currently pay dividends.

What is ZYUS Life Sciences’s EPS estimate?

ZYUS Life Sciences’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does ZYUS Life Sciences have?

ZYUS Life Sciences has 80,522,810 shares outstanding.

What happened to ZYUS Life Sciences’s price movement after its last earnings report?

ZYUS Life Sciences reported an EPS of -C$0.038 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of ZYUS Life Sciences?

Currently, no hedge funds are holding shares in TSE:ZYUS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description